Skip to main content
RSC Advances logoLink to RSC Advances
. 2025 Aug 12;15(34):27923. doi: 10.1039/d5ra90090e

Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Zhenbin Xu a, Hongpeng Duan a, Yuling Shi a,b, Zixia Zhou a,b, Zhuo Wei a,b, Xuechen Qian a, Jian Lu a, Yuemingming Jiang a, Feng Mao a, Nianyu Xue a, Shengmin Zhang a,b,✉
PMCID: PMC12376791  PMID: 40861305

Abstract

Correction for ‘Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer’ by Zhenbin Xu et al., RSC Adv., 2025, 15, 23136–23145, https://doi.org/10.1039/D5RA01016K.


The authors regret the omission of a funding acknowledgement in the original article. This acknowledgement is given here.

Acknowledgements

This research was critically supported by the following grants: Natural Science Foundation of Zhejiang Province (no. LBY23H180003) and Medical Science and Health Technology Project of Zhejiang Province (no. 2022KY319, 2022KY1065, and 2023KY1077).

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES